Microbiome Manufacturing Market Size is valued at USD 27.3 Mn in 2023 and is predicted to reach USD 84.8 Mn by the year 2031 at a 15.4% CAGR during the forecast period for 2024-2031.
Microbiome manufacture integrates sophisticated biotechnological techniques with a deep comprehension of microbial ecosystems, rendering it a state-of-the-art field of advancement with extensive implications for medicine, nutrition, and general health. The microbiome manufacturing market is at the cutting edge of scientific progress because it focuses on changing and using microbiomes for a wide range of reasons. At its core, this market is about making products and medicines based on microbiomes. These can be anything from medical treatments to consumer goods. Microbiomes are complex groups of microorganisms that live in different environments. They are becoming more and more important for human health, crops, and the long-term health of the environment.
Live biotherapeutic products (LBP), a class of microbiome therapy, involve the use of live microorganisms, such as bacteria, viruses, or fungi, to prevent or treat various disease conditions. LBPs are specifically designed for therapeutic purposes and are regulated as medicinal products or biologics in many countries. Live biotherapeutic products (LBP), a class of microbiome therapy, involve the use of live microorganisms, such as bacteria, viruses, or fungi, to prevent or treat various disease conditions.
However, outsourcing microbiome therapeutics manufacturing to CMOs and CDMOs has emerged as a lucrative option for human microbiome therapy developers to overcome existing manufacturing issues. Furthermore, increasing R&D activities, government steps to use effective components for production, and investments by key players are factors expected to create lucrative revenue growth gateways for players operating in the global microbiome manufacturing market over the forecast period.
The Microbiome Manufacturing Market is segmented into type of product manufactured, formulation, primary packaging used, scale of operation and company size. By Type of Product Manufactured, the market comprises API, FDF. According to the Formulation, market is segmented into solid, Liquid, and Others. As per the Primary Packaging Used, market is categorized into Blister Packs, Glass / Plastic Bottles, Pouches / Sachets, and Vials. According to the Scale of Operation, market segmentation includes Clinical and Commercial. As per Company Size, the market is divided into Small, Mid-sized, Large, and Very Large.
In the Microbiome Manufacturing Market, the API (Active Pharmaceutical Ingredient) segment is a major contributor mainly because of its crucial role in the production of microbiome-based therapies. APIs serve as the core component responsible for the therapeutic activity of these treatments. With increasing research focusing on microbiome-based interventions for various diseases, such as gastrointestinal disorders and immune-related conditions, the demand for APIs tailored to these therapies is rising. Moreover, advancements in microbiome research and manufacturing technologies are driving the growth of the API segment, further solidifying its position as a key player in the microbiome manufacturing landscape.
The Blister Packs segment is experiencing rapid growth in the Microbiome Manufacturing Market due to its advantages in preserving and delivering microbiome-based therapeutics. Blister packs offer superior protection against environmental factors, ensuring the stability and efficacy of live microbial products. Additionally, their convenience and dose accuracy enhance patient compliance and enable easy administration. As microbiome-based therapies gain traction for various medical conditions, including gastrointestinal disorders and immune-related diseases, the demand for blister packs as a preferred packaging solution is surging. This trend underscores the pivotal role of packaging innovations in driving the expansion of the microbiome manufacturing industry.
The North America Microbiome Manufacturing Market is expected to register the greatest market share in terms of revenue in the near future. This can be attributed to an increase in lifestyle illnesses, a greater stress on human microbiome therapeutics, and increased technological achievements in the human microbiome and next-generation sequencing. In addition, huge government research projects, such as the Human Microbiome Project in the USA, have boosted microbiome research. Many firms are also developing microbiome medicines. In addition, Europe is expected to grow at a rapid rate in the global Microbiome Manufacturing Market due to increasing concerns related to the environment, rapid urbanization, government initiatives, and increasing funding in various industries.
| Report Attribute | Specifications |
| Market Size Value In 2023 | USD 27.3 Mn |
| Revenue Forecast In 2031 | USD 84.8 Mn |
| Growth Rate CAGR | CAGR of 15.4% from 2024 to 2031 |
| Quantitative Units | Representation of revenue in US$ Million and CAGR from 2024 to 2031 |
| Historic Year | 2019 to 2023 |
| Forecast Year | 2024-2031 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Type Of Product Manufactured, Formulation, Primary Packaging Used, Scale Of Operation And Company Size |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; Southeast Asia; South Korea |
| Competitive Landscape | Arranta Bio, BacThera, Biose, BJP Laboratories, Capsugel, Cerbios-Pharma, Chr. Hansen, Inpac Probiotics, NIZO, WACKER and Winclove |
| Customization Scope | Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing And Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Microbiome Manufacturing Market By Type of Product Manufactured -
Microbiome Manufacturing Market By Formulation-
Microbiome Manufacturing Market By Primary Packaging Used-
Microbiome Manufacturing Market By Scale of Operation-
Microbiome Manufacturing Market By Company Size-
Microbiome Manufacturing Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Microbiome Manufacturing Market Snapshot
Chapter 4. Global Microbiome Manufacturing Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Type of Product Manufactured Estimates & Trend Analysis
5.1. by Type of Product Manufactured & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Type of Product Manufactured:
5.2.1. API
5.2.2. FDF
Chapter 6. Market Segmentation 2: by Type of Formulation Estimates & Trend Analysis
6.1. by Type of Formulation & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Type of Formulation:
6.2.1. Solid
6.2.2. Liquid
6.2.3. Others
Chapter 7. Market Segmentation 3: by Type of Primary Packaging Used Estimates & Trend Analysis
7.1. by Type of Primary Packaging Used & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Type of Primary Packaging Used:
7.2.1. Blister Packs
7.2.2. Glass / Plastic Bottles
7.2.3. Pouches / Sachets
7.2.4. Vials
Chapter 8. Market Segmentation 4: by Scale of Operation Estimates & Trend Analysis
8.1. by Scale of Operation & Market Share, 2019 & 2031
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Scale of Operation:
8.2.1. Clinical
8.2.2. Commercial
Chapter 9. Market Segmentation 5: by Company Size Estimates & Trend Analysis
9.1. by Company Size & Market Share, 2019 & 2031
9.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Company Size:
9.2.1. Small
9.2.2. Mid-sized
9.2.3. Large and Very Large
Chapter 10. Microbiome Manufacturing Market Segmentation 6: Regional Estimates & Trend Analysis
10.1. North America
10.1.1. North America Microbiome Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Type of Product Manufactured, 2019-2031
10.1.2. North America Microbiome Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Type of Formulation, 2019-2031
10.1.3. North America Microbiome Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Type of Primary Packaging Used, 2019-2031
10.1.4. North America Microbiome Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Scale of Operation, 2019-2031
10.1.5. North America Microbiome Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Company Size,2019-2031
10.1.6. North America Microbiome Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
10.2. Europe
10.2.1. Europe Microbiome Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Type of Product Manufactured, 2019-2031
10.2.2. Europe Microbiome Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Type of Formulation, 2019-2031
10.2.3. Europe Microbiome Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Type of Primary Packaging Used, 2019-2031
10.2.4. Europe Microbiome Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Scale of Operation,2019-2031
10.2.5. Europe Microbiome Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Company Size,2019-2031
10.2.6. Europe Microbiome Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
10.3. Asia Pacific
10.3.1. Asia Pacific Microbiome Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Type of Product Manufactured, 2019-2031
10.3.2. Asia Pacific Microbiome Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Type of Formulation, 2019-2031
10.3.3. Asia-Pacific Microbiome Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Type of Primary Packaging Used, 2019-2031
10.3.4. Asia Pacific Microbiome Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Scale of Operation,2019-2031
10.3.5. Asia Pacific Microbiome Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Company Size, 2019-2031
10.3.6. Asia Pacific Microbiome Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
10.4. Latin America
10.4.1. Latin America Microbiome Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Type of Product Manufactured, 2019-2031
10.4.2. Latin America Microbiome Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Type of Formulation, 2019-2031
10.4.3. Latin America Microbiome Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Type of Primary Packaging Used, 2019-2031
10.4.4. Latin America Microbiome Manufacturing Market Revenue (US$ Million) Estimates and Forecasts Scale of Operation, 2019-2031
10.4.5. Latin America Microbiome Manufacturing Market Revenue (US$ Million) Estimates and Forecasts Company Size,2019-2031
10.4.6. Latin America Microbiome Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
10.5. Middle East & Africa
10.5.1. Middle East & Africa Microbiome Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Type of Product Manufactured, 2019-2031
10.5.2. Middle East & Africa Microbiome Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Type of Formulation, 2019-2031
10.5.3. Middle East & Africa Microbiome Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Type of Primary Packaging Used, 2019-2031
10.5.4. Middle East & Africa Microbiome Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Scale of Operation, 2019-2031
10.5.5. Middle East & Africa Microbiome Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Company Size2019-2031
10.5.6. Middle East & Africa Microbiome Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles
11.2.1. Arranta Bio
11.2.2. BacThera
11.2.3. Biose
11.2.4. BJP Laboratories
11.2.5. Capsugel
11.2.6. Cerbios-Pharma
11.2.7. Chr. Hansen
11.2.8. Inpac Probiotics
11.2.9. NIZO
11.2.10. WACKER
11.2.11. Winclove
11.2.12. Other Prominent Players
Microbiome Manufacturing Market By Type of Product Manufactured -
Microbiome Manufacturing Market By Formulation-
Microbiome Manufacturing Market By Primary Packaging Used-
Microbiome Manufacturing Market By Scale of Operation-
Microbiome Manufacturing Market By Company Size-
Microbiome Manufacturing Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-